By NewsDesk  @infectiousdiseasenews On Wednesday, Connecticut Governor Ned Lamont  signed into law legislation that updates Connecticut’s immunization requirements for students attending preK-12...

By NewsDesk  @infectiousdiseasenews The  Finnish Institute for Health and Welfare (THL) will consider the inclusion of the Johnson & Johnson coronavirus vaccine in the Finnish vaccine programme...

Both mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) authorized and recommended in the United States protect against COVID-19-related hospitalization among adults 65 years and older, according to...

By NewsDesk  @infectiousdiseasenews The Swedish Public Health Agency has decided that Janssen’s vaccine, just like AstraZeneca’s vaccine, should only be recommended for people born in 1956...

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Johnson...

Nearly 19 million more American adults – about a third of those now refusing to get vaccinated – would get vaccinated if they could take a pill instead of getting a shot, according to a poll conducted...

The City of Chicago will move to Phase 2 of COVID-19 vaccine eligibility on April 19, meaning all Chicagoans age 16 or older are eligible to get vaccinated against COVID-19. To date, more than 1 million...

By NewsDesk  @infectiousdiseasenews The results of the first clinical trial of a new vaccine for a neglected tropical disease have demonstrated that it is safe and induces immune responses in patients...

Vaccine company, Valneva, announced that it has completed recruitment for the pivotal Phase 3 trial, VLA1553-301, of its single-shot chikungunya vaccine candidate, VLA1553. The sponsor of the first chikungunya...

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare...